AI Article Synopsis
- Cidofovir is a drug that targets DNA viruses, including HPV, but its effectiveness in immunocompromised patients is unclear.
- This report highlights the successful use of intravenous cidofovir in a patient with myelodysplastic syndrome to heal stubborn warts.
- The case suggests potential benefits of cidofovir for treating warts in patients with weakened immune systems, but more research is needed.
Article Abstract
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1468-3083.2006.01380.x | DOI Listing |
Publication Analysis
Top Keywords
intravenous cidofovir
8
cidofovir treatment
8
recalcitrant warts
8
patient myelodysplastic
8
myelodysplastic syndrome
8
treatment recalcitrant
4
warts setting
4
setting patient
4
syndrome cidofovir
4
cidofovir acyclic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!